| 产品详情 |
| Edit |   |
|---|
| Product Name | 2-[(2-Pyrazinylcarbonyl)-Bortezomib |
|---|
| Description | 2-[(2-Pyrazinylcarbonyl)-Bortezomib is a derivative of Bortezomib (B675700) which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. Bortezomib is a reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Molecular Formula: C24H27BN6O5 Molecular Weight: 490.32 |
|---|
| Size | 1mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 414471 |
|---|
| Price | |
|---|
| Order / More Info | 2-[(2-Pyrazinylcarbonyl)-Bortezomib from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|